Insulet Corp (PODD)
164.66
-1.55
(-0.93%)
USD |
NASDAQ |
Apr 18, 16:00
164.66
0.00 (0.00%)
After-Hours: 16:38
Insulet Price: 164.66 for April 18, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Apr 17, 2024 | 172.71 | 173.74 | 165.10 | 166.21 | 591165.0 |
| Apr 16, 2024 | 172.87 | 174.82 | 168.05 | 172.71 | 656034.0 |
| Apr 15, 2024 | 176.42 | 178.42 | 173.81 | 173.94 | 818337.0 |
| Apr 12, 2024 | 177.63 | 178.49 | 174.12 | 175.22 | 680529.0 |
| Apr 11, 2024 | 179.10 | 180.01 | 174.30 | 179.65 | 696787.0 |
| Apr 10, 2024 | 174.08 | 177.64 | 172.26 | 177.41 | 695269.0 |
| Apr 09, 2024 | 171.20 | 179.48 | 170.28 | 178.01 | 939948.0 |
| Apr 08, 2024 | 166.30 | 170.18 | 165.04 | 170.04 | 1.094M |
| Apr 05, 2024 | 163.05 | 165.97 | 161.68 | 165.00 | 573062.0 |
| Apr 04, 2024 | 165.73 | 167.27 | 162.86 | 163.25 | 451166.0 |
| Apr 03, 2024 | 163.25 | 166.00 | 163.25 | 164.86 | 432358.0 |
| Apr 02, 2024 | 166.51 | 166.98 | 163.05 | 164.05 | 735505.0 |
| Apr 01, 2024 | 171.27 | 171.78 | 165.82 | 168.10 | 757228.0 |
| Mar 28, 2024 | 170.00 | 172.21 | 169.22 | 171.40 | 786601.0 |
| Mar 27, 2024 | 167.10 | 169.25 | 162.47 | 169.18 | 996108.0 |
| Mar 26, 2024 | 167.07 | 167.07 | 163.11 | 165.52 | 595773.0 |
| Mar 25, 2024 | 165.62 | 165.90 | 163.13 | 164.75 | 828541.0 |
| Mar 22, 2024 | 166.75 | 166.75 | 162.05 | 164.31 | 623099.0 |
| Mar 21, 2024 | 169.06 | 170.38 | 166.28 | 166.64 | 432909.0 |
| Mar 20, 2024 | 170.81 | 171.86 | 162.55 | 167.20 | 991466.0 |
| Mar 19, 2024 | 171.07 | 171.85 | 164.02 | 170.61 | 1.207M |
| Mar 18, 2024 | 165.11 | 173.76 | 164.08 | 171.68 | 840266.0 |
| Mar 15, 2024 | 166.23 | 168.76 | 165.47 | 165.86 | 827957.0 |
| Mar 14, 2024 | 175.54 | 176.22 | 163.60 | 167.70 | 1.056M |
| Mar 13, 2024 | 182.00 | 183.50 | 175.33 | 175.54 | 549146.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
82.13
Minimum
Apr 18 2019
330.23
Maximum
May 12 2023
227.57
Average
234.10
Median
Jan 18 2022
Price Benchmarks
| Abbott Laboratories | 105.27 |
| Stryker Corp | 327.60 |
| Becton Dickinson & Co | 233.15 |
| Haemonetics Corp | 83.47 |
| Tandem Diabetes Care Inc | 30.93 |
Price Related Metrics
| PE Ratio | 56.58 |
| PS Ratio | 7.230 |
| PEG Ratio | 0.0119 |
| Price to Book Value | 15.71 |
| Price to Free Cash Flow | 336.16 |
| Earnings Yield | 1.77% |
| Market Cap | 11.51B |
| PEGY Ratio | 0.0119 |
| Operating PE Ratio | 55.77 |
| Normalized PE Ratio | 56.58 |